Cogent Biosciences
Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases, using validated biology and targeted drug discovery approaches.
The company is advancing multiple clinical trials for targeted therapeutics, including bezuclastinib for systemic mastocytosis and GIST, and is working on expanding its portfolio based on genetic mutations.
The organization encourages innovation, collaboration, and continuous learning to transform treatment options for serious diseases.
Headquarters
Waltham, Massachusetts, United States
Company Size
51-200 employees
Founded
2014
Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases, including cancers, autoimmune conditions, and rare diseases. The company leverages validated biology to design best-in-class small molecule therapeutics, with its lead program bezuclastinib targeting conditions such as Systemic Mastocytosis and Gastrointestinal Stromal Tumors (GIST). Cogent operates discovery and development offices in Boulder, Colorado and Waltham, Massachusetts, and is actively advancing clinical-stage programs including a Phase 3 trial and an FDA-accepted NDA for bezuclastinib.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Cogent Biosciences.
154% above the average for this role
Sep 3, 2019
Director, Imaging Biomarkers
Dyne Therapeutics
Sr Director, Global Translational Sciences Lead, Molecular Imaging
City of Duncan, Oklahoma
Clinical Trial Associate, Oncology, EMEA
Eikon Therapeutics
Research Associate/ SRA (Glaucoma)
Character Bio
Research Associate
Character Bio
Basic and Translational Discovery Scientists in Gene Editing / Clinician Investigators in In Vivo Gene Editing and Therapeutic Delivery
Charterhouse